News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Starpharma.
RELATED STOCKHEAD STORIES
News
Last Orders: Small caps retreat for 2nd day, but Zip closes at ATH
News
ASX Small Cap Lunch Wrap: Small caps drop, but Afterpay breaks ATH at $159
Health & Biotech
$2bn R&D win for biotech, resources
Experts
ScoPo’s Health Powerplays: Biotechs hitting it out of the park
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health Kick Podcast: Starpharma goes from strength to strength following news of progress on COVID-19 nasal spray
Health & Biotech
COVID has opened up potentially lucrative opportunities for these Aussie microcaps
Experts
Scopo’s Health Powerplays: Show me the (grant) money
Health & Biotech
Check up: Health sector slips as earning season ends
Health & Biotech
G Medical to delist from ASX despite a May promise to stay
Health & Biotech
COVID-19 treatments are a better bet than a vaccine
Health & Biotech
Going viral: All the biggest COVID-19 news from the last week
Health & Biotech
Big gains for two ASX pharma stocks as investors stay on the hunt for potential COVID-19 solutions
Health & Biotech
Health: Neuren gets extra FDA push for its treatment for rare Rett disease
Health & Biotech
Here’s how to pick a successful drug out of the 99pc of failures
Health & Biotech
